Proactive Investors - Run By Investors For Investors

Pressure BioSciences has an eye toward uplisting as it strengthens balance sheet

Pressure BioSciences (OTCMKTS:PBIO, OTCQB: PBIO) CEO Ric Schumacher tells Proactive Investors the life sciences company has strengthened its balance sheet with the conversion of an additional $7.24mln of debt into equity, bringing the total amount of debt that has converted into equity over the past four weeks to more than $13.6mln.

Schumacher says the company is on track to uplist to a national exchange, and would like to make the move by the end of the year.

 
View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use